Bitdeer Technologies
BTDR
Mawson Infrastructure
MIGI
Digihost Technology
DGHI
Canaan
CAN
Intchains Group
ICG
US Stock MarketDetailed Quotes
CRNX Crinetics
- 32.550
- +0.250+0.77%
Close Feb 26 16:00 ET
- 32.550
- 0.0000.00%
Post 20:01 ET
3.02BMarket Cap-8.80P/E (TTM)
33.503High32.160Low1.08MVolume32.550Open32.300Pre Close35.35MTurnover1.18%Turnover RatioLossP/E (Static)92.74MShares62.53052wk High3.62P/B2.98BFloat Cap31.84052wk Low--Dividend TTM91.46MShs Float62.530Historical High--Div YieldTTM4.16%Amplitude10.630Historical Low32.696Avg Price1Lot Size
Crinetics News
Crinetics Pharmaceuticals Hires CFO From Revance
Express News | Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Press Release: Crinetics Pharmaceuticals Appoints Tobin Schilke as Chief Financial Officer
Earnings Preview: Crinetics to Report Financial Results Post-market on February 27
Crinetics Pharmaceuticals to Participate in Two Upcoming March Investor Conferences
Congress Trade: Representative Gilbert Ray Cisneros, Jr. Just Disclosed New Stock Trades
TD Cowen Initiates Crinetics(CRNX.US) With Buy Rating
Crinetics Initiated With a Buy at TD Cowen
Express News | Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Crinetics Pharmaceuticals Announces February 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Wolfe Research Initiates Coverage on Crinetics Pharmaceuticals With Peer Perform Rating
Wolfe Research Initiates Crinetics(CRNX.US) With Hold Rating
What Are Analysts Talking About Crinetics Pharmaceuticals (CRNX)?
This Netflix Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Jefferies Upgrades Crinetics(CRNX.US) to Buy Rating, Maintains Target Price $55
Is Crinetics Pharmaceuticals (CRNX) Among Billionaire Joseph Edelman's Long-Term Stock Picks?
Crinetics Pharmaceuticals, Inc. (CRNX): The Biotech Stock With Biggest Upside Potential
While Crinetics Pharmaceuticals (NASDAQ:CRNX) Shareholders Have Made 75% in 3 Years, Increasing Losses Might Now Be Front of Mind as Stock Sheds 27% This Week
Oppenheimer Maintains Crinetics(CRNX.US) With Buy Rating, Maintains Target Price $73
Trending Stocks
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks
Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.